Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls

European Journal of Endocrinology

Volumn 165, Issue 5, 2011, Pages 753-760

  Amstrup, Anne Kristine ^a,b   Rejnmark, Lars ^a   Mosekilde, Leif ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EMOTION; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36; WHO FIVE WELL BEING INDEX;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROIDECTOMY; POPULATION SURVEILLANCE; QUALITY OF LIFE; SEASONS;

EID: 80054823551     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0301     Document Type: Article

References (41)

1. Vestergaard P & Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ 2003 327 530-534. (doi:10.1136/bmj.327.7414.530)
2. Fraser WD. Hyperparathyroidism. Lancet 2009 374 145-158. (doi:10.1016/S0140-6736(09)60507-9)
3. Vestergaard P & Mosekilde L. Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World Journal of Surgery 2003 27 343-349. (doi:10.1007/s00268- 002-6589-9)
4. Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert- Toft M & Mosekilde L. Cardiovascular events before and after surgery for primary hyperparathyroidism. World Journal of Surgery 2003 27 216-222. (doi:10.1007/s00268-002-6589-9)
5. Burney RE, Jones KR, Peterson M, Christy B & Thompson NW. Surgical correction of primary hyperparathyroidism improves quality of life. Surgery 1998 124 987-991. (doi:10.1016/S0039- 6060(98)70039-X)
6. Quiros RM, Alef MJ, Wilhelm SM, Djuricin G, Loviscek K & Prinz RA. Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 2003 134 675-681. (doi:10.1016/S0039-6060(03)00316-7)
7. Sheldon DG, Lee FT, Neil NJ & Ryan JA Jr. Surgical treatment of hyperparathyroidismimproves health-related quality of life. Archives of Surgery 2002 137 1022-1028. (doi:10.1001/archsurg.137.9. 1022)
8. Pasieka JL, Parsons LL, Demeure MJ,Wilson S, Malycha P, Jones J & Krzywda B. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World Journal of Surgery 2002 26 942-949. (doi:10.1007/s00268-002-6623-y)
9. Weber T, Keller M, Hense I, Pietsch A, Hinz U, Schilling T, Nawroth P, Klar E & Buchler MW. Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World Journal of Surgery 2007 31 1202-1209. (doi:10.1007/ s00268-007-9006-6)
10. Walker MD, McMahon DJ, Inabnet WB, Lazar RM, Brown I, Vardy S, Cosman F & Silverberg SJ. Neuropsychological features in primary hyperparathyroidism: a Prospective Study. Journal of Clinical Endocrinology and Metabolism 2009 94 1951-1958. (doi:10.1210/jc.2008-2574)
11. Joborn C, Hetta J, Lind L, Rastad J, Akerstrom G & Ljunghall S. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery 1989 105 72-78. (Pubitemid 19025086)
12. Mjaland O, Normann E, Halvorsen E, Rynning S & Egeland T. Regional cerebral blood flow in patients with primary hyperparathyroidism before and after successful parathyroidectomy. British Journal of Surgery 2003 90 732-737. (doi:10.1002/bjs.4131)
13. Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F & Baulieu EE. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. Journal of Clinical Endocrinology and Metabolism 2001 86 3086-3090. (doi:10.1210/jc.86.7.3086)
14. Souberbielle JC, Lawson-Body E, Hammadi B, Sarfati E, Kahan A & Cormier C. The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 3501-3504. (doi:10.1210/jc.2003-030097)
15. Cockcroft DW& Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 31-41. (doi:10.1159/000 180580)
16. Maunsell Z, Wright DJ & Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clinical Chemistry 2005 51 1683-1690. (doi:10.1373/clinchem.2005.052936)
17. Hojskov CS, Heickendorff L & Moller HJ. High-throughput liquid-liquid extraction and LC-MS/MS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clinica Chimica Acta 2010 411 114-116. (doi:10. 1016/j.cca.2009.10.010)
18. Bjorner JB, Thunedborg K, Kristensen TS, Modvig J & Bech P. The Danish SF-36 Health Survey: translation and preliminary validity studies. Journal of Clinical Epidemiology 1998 51 991-999. (doi:10.1016/S0895-4356(98) 00091-2)
19. Bech P, Olsen LR, Kjoller M & Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-FiveWell-being scale. International Journal of Methods in Psychiatric Research 2003 12 85-91. (doi:10.1002/mpr.145)
20. Caillard C, Sebag F, Mathonnet M, Gibelin H, Brunaud L, Loudot C, Kraimps JL, Hamy A, Bresler L, Charbonnel B, Leborgne J, Henry JF, Nguyen JM & Mirallie E. Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 2007 141 153-159. (doi:10.1016/j.surg.2006.12.004)
21. Edwards ME, Rotramel A, Beyer T, Gaffud MJ, Djuricin G, Loviscek K, Solorzano CC & Prinz RA. Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up. Surgery 2006 140 655-663. (doi:10.1016/j.surg.2006.06.016)
22. Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T & on behalf on the SIPH Study Group. Medical Observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. Journal of Clinical Endocrinology and Metabolism 2007 92 1687-1692. (doi:10.1210/jc.2006-1836)
23. Rao DS, Phillips ER, Divine GW & Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2004 89 5415-5422. (doi:10.1210/jc.2004-0028)
24. Abraham-Nordling M, Torring O, Hamberger B, Lundell G, Tallstedt L, Calissendorff J & Wallin G. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid 2005 15 1279-1286. (doi:10.1089/thy.2005.15. 1279)
25. Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF & Wiersinga W. Long-term effects of Graves' ophthalmopathy on health-related quality of life. European Journal of Endocrinology 2002 146 751-757. (doi:10.1530/eje.0.1460751)
26. Bjorner JB, Wallenstein GV, Martin MC, Lin P, Blaisdell-Gross B, Tak PC & Mody SH. Interpreting score differences in the SF-36 vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Current Medical Research and Opinion 2007 23 731-739. (doi:10.1185/030079907X178757)
27. Bolland MJ, Grey AB, Gamble GD & Reid IR. Association between primary hyperparathyroidism and increased body weight: a metaanalysis. Journal of Clinical Endocrinology and Metabolism 2005 90 1525-1530. (doi:10.1210/jc.2004- 1891)
28. Grey A & Reid I. Body weight and bone mineral density in hyperparathyroidism. Annals of Internal Medicine 1995 123 732.
29. Maltais ML, Desroches J & Dionne IJ. Changes in muscle mass and strength after menopause. Journal of Musculoskeletal and Neuronal Interactions 2009 9 186-197.
30. Amstrup AK, Rejnmark L, Vestergaard P, Sikjaer T, Rolighed L, Heickendorff L & Mosekilde L. Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional study. Clinical Endocrinology 2011 74 130-136. (doi:10.1111/j.1365-2265.2010.03906.x)
31. Jones GL & Sutton A. Quality of life in obese postmenopausal women. Menopause International 2008 14 26-32. (doi:10.1258/ mi.2007.007034)
32. Karlsson J, Taft C, Sjostrom L, Torgerson JS & Sullivan M. Psychosocial functioning in the obese before and after weight reduction: construct validity and responsiveness of the obesity-related problems scale. International Journal of Obesity and Related Metabolic Disorders 2003 27 617-630. (doi:10.1038/sj.ijo. 0802272)
33. Myint PK, Welch AA, Luben RN, Wainwright NW, Surtees PG, Bingham SA, Wareham NJ, Smith RD, Harvey IM & Khaw KT. Obesity indices and self-reported functional health in men and women in the EPIC-Norfolk. Obesity 2006 14 884-893. (doi:10. 1038/oby.2006.102)
34. Romagnoli E, Carnevale V, Nofroni I, D'Erasmo E, Paglia F, De Geronimo S, Pepe J, Raejntroph N, Maranghi M & Minisola S. Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures. Osteoporosis International 2004 15 975-980. (doi:10. 1007/s00198-004-1633-2)
35. Lima MG, Barros MB, Cesar CL, Goldbaum M, Carandina L & Ciconelli RM. Impact of chronic disease on quality of life among the elderly in the state of Sao Paulo, Brazil: a population-based study. Revista Panamericana de Salud Pública 2009 25 314-321. (doi:10.1590/S1020-49892009000400005)
36. Wang R, Zhao Y, He X, Ma X, Yan X, Sun Y, Liu W, Gu Z, Zhao J & He J. Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public Health 2009 123 534-539. (doi:10.1016/j.puhe. 2009.06.009)
37. Trevisol DJ, Moreira LB, Kerkhoff A, Fuchs SC & Fuchs FD. Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies. Journal of Hypertension 2011 29 179-188. (doi:10.1097/HJH.0b013e328340d76f)
38. Bensalah K, Tuncel A, Gupta A, Raman JD, Pearle MS & Lotan Y. Determinants of quality of life for patients with kidney stones. Journal of Urology 2008 179 2238-2243. (doi:10.1016/j.juro. 2008.01.116)
39. Walker MD & Silverberg SJ. Parathyroidectomy in asymptomatic primary hyperparathyroidism: improves "bone" but not "psychic moans". Journal of Clinical Endocrinology and Metabolism 2007 92 1613-1615. (doi:10.1210/jc.2007-0551)
40. Bilezikian JP, Khan AA & Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. Journal of Clinical Endocrinology and Metabolism 2009 94 335-339. (doi:10.1210/jc.2008-1763)
41. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J & Silverberg SJ. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. Journal of Clinical Endocrinology and Metabolism 2008 93 3462-3470. (doi:10.1210/jc.2007-1215)